vialroom

#retatrutide 2026-03-30

Monday13 messages5 participantstimes are UTC
Highlights from this day
  • sasha_stacks — energy expenditure isnt something i could feel, though my sleep tracker disagreed with me 19:50
  • VialBot — Channel stats, last 30 days: 105 messages from 32 members. 21:03
  • seven_five_sweet — im at 7.5 and the appetite effect is stronger than i expected, normal 21:25
NT

whats the half life like, is it weekly the same way

Cited study
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
New England Journal of Medicine · 2023
48 weeks, dose-ranging. A Phase 2 result is not a safety record.
NT

back after 13 months, has anything actually been published since

❤️8🔥1
SS

energy expenditure isnt something i could feel, though my sleep tracker disagreed with me

⚠️2🧪11
SF

for the archive i said 8 months ago that my heart rate had settled and it has stayed settled since

NT

VendorInvestigate came back 99.4 on one lot and 99 on the next from the same FGP, both fine

VB

Channel stats, last 30 days: 105 messages from 32 members.

🤝13
NT

the honest position is this has less human evidence behind it than anything else discussed here
held at 0.5 for 10 months and it never plateaued for me, which i cant explain

SF

im at 7.5 and the appetite effect is stronger than i expected, normal

🧪16🎉17🤝14
SF

TRIUMPH is the phase 3 programme, thats the name to search rather than the molecule, happy to be corrected

NT

my resting heart rate is up about 8 bpm, did that settle for anyone
GI was about the same as tirzepatide for me, the difference was how fast it arrived

NT

buying this is a completely different risk conversation from the licensed compounds and that gets said too rarely

OO

lost 42kg over 1 months at doses well under what the trials used

👍8